Does Rectal Indomethacin Eliminate the Need for Prophylactic Pancreatic Stent Placement in Patients Undergoing High-Risk ERCP? Post hoc Efficacy and Cost-Benefit Analyses Using Prospective Clinical Trial Data

OBJECTIVES: A recent large-scale randomized controlled trial (RCT) demonstrated that rectal indomethacin administration is effective in addition to pancreatic stent placement (PSP) for preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in high-risk cases. We per...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Elmunzer, B. Joseph, Higgins, Peter D.R., Saini, Sameer D., Scheiman, James M., Parker, Robert A., Chak, Amitabh, Romagnuolo, Joseph, Mosler, Patrick, Hayward, Rodney A., Elta, Grace H., Korsnes, Sheryl J., Schmidt, Suzette E., Sherman, Stuart, Lehman, Glen A., Fogel, Evan L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947644/
https://ncbi.nlm.nih.gov/pubmed/23295278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ajg.2012.442
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados